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SUMMARY – Usage of complementary and alternative medicine (CAM) is steadily increasing 
over the last decades, gaining medical, economic and sociological importance. Th e aim of the present 
study was to assess the use of complementary and alternative therapies in cancer patients. A cross-
sectional, descriptive survey design was used to collect data through an anonymous questionnaire. A 
total of 267 patients were included in the study. Th e prevalence of CAM use among cancer patients in 
this study was 60.3%. It was found that 61 heterogeneous CAM therapies were used, the most popu-
lar among patients being naturopathy/folk medicine. In multivariate logistic regression analysis, inde-
pendent predictors of CAM use were high income, divorced status, female sex and younger age. In 
conclusion, considering the fact that a large proportion of patients used at least one CAM approach, 
we need to continue our eff orts to improve the patient-oncologist communication in order to deliver 
most reliable information to patients and to better understand the possible standard medicine-CAM 
interactions. According to results of the latest studies, CAM therapies that help manage pain, nausea, 
fatigue, anxiety, and other symptoms should be integrated into the patient overall care.
Key words: Alternative medicine; Cancer; Complementary medicine; Oncology; Croatia
Correspondence to: Davor Kust, MD PhD, Clinical Department of 
Oncology and Nuclear Medicine, Sestre milosrdnice University 
Hospital Center, Vinogradska c. 29, HR-10000 Zagreb, Croatia
E-mail: davor.kust@gmail.com
Received May 18, 2016, accepted September 28, 2016
Introduction
Complementary and alternative medicine (CAM) 
has been defi ned as “any diagnosis, treatment or pre-
vention that complements mainstream medicine by 
contributing to a common whole, by satisfying a de-
mand not met by orthodoxy, or by diversifying the 
conceptual framework of medicine”1. Additionally, 
some of these therapies are developed not to comple-
ment but to substitute the mainstream Western medi-
cine, thus being ‘alternative’. Th is defi nition includes a 
large variety of behavioral techniques and clinical ap-
proaches, including special diets, naturopathy, home-
opathy, manipulative and psychological therapy, and 
many others. A common feature of all these techniques 
and approaches is that their eff ectiveness is still un-
proven, since no large clinical trials were conducted, 
although sellers of these products and promoters of 
alternative lifestyle, as well as some of the patients 
claim that they successfully treat cancer. Some success 
has been achieved in relieving cancer symptoms and 
lowering toxicity of standard treatment, such as man-
agement of chemotherapy-related nausea and vomit-
ing with acupuncture, and pain relief with self-hypno-
sis, massage or acupuncture2,3.
Regardless of the lack of defi nitive scientifi c evi-
dence for CAM, its popularity increases steadily over 
time, gaining medical, economic and sociological im-
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portance, especially when high cost of many of these 
therapies is taken into account4. It is estimated that 
CAM is used by 30%-40% of cancer patients in devel-
oped countries, although some studies report a preva-
lence as high as 64%4,5. Although the reasons for the 
current high popularity of these alternative treatments 
are complex and not fully understood, desperation, the 
need to do ‘everything that can be done’, specifi c pa-
tient beliefs about medicine, as well as specifi c social 
context and cultural diff erences could be recognized as 
motives6. Also, the role of social media is of great im-
portance, mainly in negative sense, since unverifi ed 
and incorrect information is sometimes published, in 
order to expand the scope and popularity of CAM.
Th is is the fi rst study conducted in Croatia, a recent 
European Union member, on the status of CAM in 
cancer patients. Th e aim of the study was to assess the 
use of complementary and alternative therapies in 
cancer patients in Croatia, using the same measure-
ment tool and the same defi nition of CAM. Asking 
the patient about the use of CAM is important, since 
most of the cancer patients using alternative medicine 
also attend oncologists. Th ere is a possibility of drug 
interactions and unexplainable side eff ects that may 
not be correctly interpreted due to the physician’s ig-
norance about the whole spectrum of therapy in a par-
ticular patient.
Patients and Methods
A cross-sectional descriptive survey design was 
used to collect data through an anonymous question-
naire about CAM therapies, from October 2014 to 
October 2015. Th e study was conducted at a high-
volume cancer center, where not only local patients but 
also those from all over the country are referred at 
some point of their disease for diagnostics, treatment 
and/or follow up. Investigators had full access to the 
patient medical records, and in the case of any unclear 
medical information regarding patients from other in-
stitutions, the leading physician was contacted. Th e 
questionnaire was designed in the mother language 
and the investigator was present during fi lling out the 
questionnaire to prevent any possible misunderstand-
ing. Th e study was conducted in accordance with ethi-
cal standards set by the institutional Ethics Commit-
tee and the Helsinki Declaration from 1975, as revised 
in 1983. An informed consent was obtained from all 
participants before their enrollment in the study. In-
cluded patients were adults with a histopathologic di-
agnosis of cancer, either metastatic or non-metastatic, 
aware of their diagnosis, able to understand the ques-
tions, and free from any condition that would make 
completing the questionnaire inappropriate or over-
burdening. Th e questionnaire was developed by the 
authors themselves. Patients were asked about demo-
graphic data (gender, age, marital status, education, 
household income) and their personal experience with 
CAM (what CAM therapy the patient used, reasons 
for using, satisfaction and perceived eff ectiveness [on a 
0-10 scale, with higher scores indicating higher levels 
of satisfaction or perceived eff ectiveness], sources of 
information or recommendation, consulting with their 
leading physician/oncologist about CAM use and po-
tential interactions with the standard cancer treatment, 
time of commencement of CAM and the length of its 
use [in the case of current use, duration of treatment 
was calculated according to the day of enrollment in 
the study], their recommendation to other patients, 
the side eff ect profi le and monthly cost of CAM ther-
apy). CAM therapies and procedures were divided into 
13 subgroups, as follows: 1) special diets and food sup-
plements (excluding vitamins and minerals in this sub-
group); 2) medicinal herbs; 3) medicinal fungi; 4) na-
turopathy and folk medicine; 5) medicinal teas; 6) vi-
tamins and minerals; 7) homeopathy; 8) specifi c di-
etary supplements; 9) acupuncture; 10) applied 
kinesiology and yoga; 11) manipulative therapy (mas-
sage, refl exology, and craniosacral therapy); 12) mind-
body intervention (spiritual therapy, healing, and en-
ergy therapy); and 13) psychological therapy (hypno-
sis, meditation, and relaxation techniques). Clinical 
data (site of primary cancer, stage of the disease, stan-
dard treatments received previously and current stan-
dard treatment) were collected directly from the pa-
tient medical records. Patients who did not report past 
or current use of CAM were also included in the study 
in order to evaluate the extent of CAM use among 
cancer patients.
Statistical analysis
Statistical signifi cance of association between the 
use of CAM and other nominal categorical variables 
was determined by c2 test. Statistical signifi cance of as-
sociation between the use of CAM and ordinal cate-
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gorical variable was determined by c2 test for trend. 
Statistical signifi cance of association between the use 
of CAM and numerical variables was determined by 
Mann-Whitney U test. Multivariate logistic regres-
sion analysis was performed to asses which variables 
predict CAM use, and all variables were included in 
the analysis. Th e analysis was performed using Med-
Calc (version 10.4.0.0, MedCalc Software bvba, Mar-
iakerke, Belgium) and p value of ≤0.05 was considered 
statistically signifi cant.
Results
All of the approached patients agreed to participate 
and gave their informed consent, and a total of 267 
patients were included in the study. Th e mean follow 
up period was 26 (median=12; range=2-228) months 
and the mean patient age 61.4 (median=61; 
range=33-83) years. Th e patients having used CAM 
(median age 60 years) were signifi cantly younger than 
the patients that did not use CAM (median age 64 
years) (Mann-Whitney U test, z=4.98, p<0.0001). Th e 
number of male and female patients was almost equal, 
134 (50.2%) and 133 (49.8%), respectively. Women 
(67%) were more likely to use CAM than men (53%) 
(c2 test=4.31, p=0.038). Basic demographic data and 
patient clinical characteristics are shown in Tables 1 
and 2. Th ere was signifi cant association between mari-
tal status and the use of CAM (c2 test=13.53, p=0.004). 
Eighty-three percent of divorced, 62% of married, 
50% of single never married, and 34% of widowed pa-
tients reported using CAM. Also, there was a signifi -
cant trend of increase in the proportion of patients us-
ing CAM with increasing education level (c2 test for 
trend=6.33, p=0.012) and with increasing income (c2 
test for trend=19.88, p<0.0001). CAM was used by 
72% of patients with university education, 59% with 
secondary education and 50% with only primary edu-
cation. Results regarding income were similar, showing 
that 94% of CAM users had high income (>800 €), 
61% average income and 50% low income (<400 €). 
Th ere was no association between the stage of disease 
and proportion of patients using CAM (c2 test=5.83, 
p=0.12). Th ere was signifi cant association between the 
type of cancer and CAM use (c2 test=50.07, p<0.0001). 
Most of the patients, i.e. 129 (48.3%) patients, had 
gastrointestinal cancer (61 colon cancer, 32 rectal can-
cer, 21 gastric cancer, 7 esophageal cancer, 3 anal can-
cer, 3 bile duct cancer, and 2 liver cancer). Primary tu-
mor sites in other patients were as follows: breast in 27 
(10.1%); skin and eye (melanoma) in 26 (9.7%); ovary 
in 12 (4.5%); thyroid in 11 (4.1%); prostate and lung in 
9 (3.4%) patients each; lymph nodes in 7 (2.6%); pleu-
ra and brain in 4 (1.5%) patients each; and larynx, uri-
nary bladder, testis, parathyroid gland, penis, orophar-
ynx, nasopharynx and adrenal gland in 2 (0.7%) pa-
tients each. In 11 (4.1%) patients, the primary tumor 
site was unknown. Patients treated with chemotherapy 
and/or targeted therapy were signifi cantly more likely 
to use CAM (c2 test=13.13, p=0.0003), whereas those 
treated with radiotherapy were signifi cantly less likely 
to use CAM (c2 test=7.28, p=0.007). Th ere was no as-
sociation between hormonal therapy and use of CAM 
(c2 test=3.71, p=0.054).
Considering CAM use, statistical analysis showed 
that 161 of 267 (60.3%) patients included in the study 
used some form of CAM. Th irteen (4.9%) patients re-
ported using special diets and food supplements in-
cluding omega-3 fatty acids, mixed fruit juices, and 
sugar-free diet (with the exception of vitamins and 
minerals); 53 (19.9%) patients used medicinal herbs 
(including turmeric, aloe vera, noni (Morinda citrifo-
lia), various herbal formulations, stone root, spelt, can-
nabis, mistletoe, mixed herbal liquid preparations, 
parsley, and ginger); 10 (3.7%) patients used medicinal 
fungi (including Tibetan milk mushroom, Cordyceps 
fungi, maitake, shiitake, lingzhi, almond and oyster 
mushroom); 108 (40.4%) patients implemented natu-
ropathy and folk medicine (including mixed beet-car-
rot-apple juice, aronia, blackberry wine, linseed, hash, 
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lavender and black-cumin oil, royal jelly, bee pollen, 
sodium bicarbonate, propolis, honey, almond, and al-
cohol-honey preparations); 17 (6.4%) patients took 
medicinal teas (including mixed herbal, lapacho (ta-
heebo), teucrium and Siberian algae tea); 10 (3.7%) 
patients used vitamins and minerals (including multi-
vitamin supplements, and vitamin C); 9 (3.4%) pa-
tients applied homeopathy (including drug containing 
peptides extracted from the blue scorpion venom, and 
zinc); 54 (20.2%) patients used specifi c dietary supple-
ments (products containing beta-glucan, amygdalin, 
arabynoxylan, soursoup, chlorophyll, quinones, and/or 
fungal extracts); none of the patients underwent acu-
puncture; 5 (1.9%) patients practiced applied kinesiol-
ogy and yoga; 3 (1.1%) patients underwent manipu-
lative therapy (including massage, refl exology, and 
craniosacral therapy); 2 (0.7%) patients underwent 
mind-body interventions (including spiritual therapy, 
healing, and energy therapy); and 3 (1.1%) patients 
used some form of psychological therapy (including 
hypnosis, meditation, and relaxation techniques). In 
total, more than 60 diff erent CAM treatments were 
used. Th e majority of patients used more than one 
CAM therapy, and the mean number of CAM per pa-
tient was 2.3 (median=2; range=1-7).
When asked about the reasons and motives for 
CAM use, most of the patients reported boosting their 
immune system, as shown in Table 3. In this study, pa-
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Table 3. Reasons and motives for CAM use (N=161)
Category n (%)
Boosting the immune system 71 (44.1%)
Convinced by friends and/or family members 18 (11.2%)
Treatment of the main disease 18 (11.2%)
Prevention of disease dissemination 15 (9.3%)
Improvement of blood fi ndings 14 (8.7%)
Reduced toxicity of standard oncologic therapy 11 (6.8%)
No specifi c reason 10 (6.2%)
Symptomatic treatment 7 (4.3%)
Detoxication 5 (3.1%)
Desperation 2 (1.2%)
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tients were generally very satisfi ed with the eff ective-
ness of CAM according to their feedback, as shown in 
Figure 1 (mean satisfaction score 6.7, median satisfac-
tion score 7). However, 139 (52.1%) patients could not 
decide whether to recommend CAM use to other can-
cer patients, 112 (41.9%) patients stated they would do 
it, while 6 (2.2%) patients would not. Th e sources of 
information on CAM are shown in Table 4. Around 
two-thirds of patients (107 or 66.5% of them) using 
CAM did not talk about alternative therapies with 
their oncologist, while 54 (33.5%) patients admitted 
using CAM to the oncologist. Among patients having 
admitted using CAM, there were signifi cantly more 
female (37/89; 41.6%) than male (17/72; 23.6%) pa-
tients (c2=4.98, p=0.026). Forty-four out of 161 pa-
tients (27.3%) using CAM had started using it right 
after the surgery, 33 (20.5%) right after the diagnosis, 
29 (18%) during chemotherapy, 21 (13%) at the begin-
ning of chemotherapy, 15 (9.3%) after disease progres-
sion or recurrence, 10 (6.2%) before the diagnosis of 
cancer, 5 (3.1%) after completion of chemotherapy, 2 
(1.2%) during radiotherapy, and 2 (1.2%) during fol-
low up. None of the patients started using CAM dur-
ing endocrine therapy or immunotherapy. Th e mean 
duration of CAM therapy was 7.81 (median=4; 
range=0.25-72) months. Th e vast majority of patients 
did not observe any side eff ects of CAM and tolerated 
it well. Four (2.5%) patients reported constipation, 3 
(1.9%) drowsiness, 3 (1.9%) vomiting, 2 (1.2%) diar-
rhea, and 2 (1.2%) burning sensation in the eyes. Th ir-
ty-seven (23%) CAM users were aware of the poten-
tial interactions between the alternative and standard 
oncologic therapy, while in 124 (77%) patients this 
problem was not addressed by medical professionals in 
contact with the patient. Th e average monthly cost 
of CAM per patient was 114 € (median=40; range=
0-1510).
In multivariate logistic regression analysis with de-
mographic and clinical (type of cancer) variables in-
cluded, independent predictors of CAM use were in-
come more than 800 € (OR=10.88, 95% CI 2.43-
48.80, p=0.002), divorced status (OR=3.95, 95% CI 
1.26-12.37, p=0.019), female sex (OR=2.02, 95% CI 
1.17-3.48, p=0.012) and younger age (OR=0.95, 95% 
CI 0.92-0.98, p=0.0003).
Discussion
In this study, the prevalence of CAM use among 
cancer patients was 60.3%, which is in accordance with 
several previously conducted studies in adult popula-
tion4,5. In pediatric population, the rates are equally 
high, ranging from 32.7% in the UK to 84% in the 
USA7,8. Signifi cant variability of the prevalence re-
ported in diff erent studies (30%-64%, or even more) 
could be explained by population diff erences, as well as 
the lack of specifi city, inconsistent defi nitions, and pa-
tient understanding of what CAM is. Additionally, the 
reported numbers refer to patients treated with stan-
dard cancer therapy and using CAM as supplementary 
treatment, while the patients using CAM as the only 
treatment modality are usually not included in these 
studies, suggesting that the prevalence of CAM use 
Fig. 1. Satisfaction with CAM treatment: patients were 
generally well satisfi ed with CAM therapies, even if they 
did not see any objective eff ects (1 – not satisfi ed at all; 
10 – fully satisfi ed).
Table 4. Sources of information about CAM used by our 
patients (N=161)
Category n (%)
Friends and/or family members 66 (41%)
Other patients 33 (20.5%)
Internet 25 (15.5%)
General practitioner 12 (7.5%)
Pharmacist 11 (6.8%)
Books, newspapers 7 (4.3%)
Television 2 (1.2%)
Alternative practitioner 2 (1.2%)
Unknown 3 (1.9%)
Grades
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among cancer patients could be even higher. Also, the 
patient openness to talk about CAM use is obviously a 
very important factor. One of the reasons for the re-
ported increased use of CAM could be that patients 
are more comfortable to talk about this topic than be-
fore, probably partly infl uenced by the wider presence 
and coverage of CAM in social media, which is in ac-
cordance with our results, suggesting that CAM users 
were signifi cantly younger than nonusers. However, 
personal and cultural diff erences, fear of developing 
confl ict of opinion with health care team, shame, and 
possibly some other unrecognized factors could cause 
non disclosure of all the types of treatment used to 
physician. An additional cause for not admitting CAM 
usage could be timing of interview regarding their dis-
ease, as patients that are interviewed after disease has 
been put under control could possibly be more open to 
admit their behavior during treatment than those that 
are still depending on treatment outcome. In a large 
European survey of CAM use, the authors have re-
ported that a signifi cant number of participants did 
not want their healthcare team to know about their use 
of CAM9. In the present study, most of the patients 
(66.5%) did not admit using CAM to their leading 
oncologist. However, this may be caused by inadequate 
patient-physician communication.
When asked to participate in the study, all patients 
agreed to it. Th ey all were very open and interested in 
the study, asked questions about CAM they used, and a 
bond and trust were developed between the patient and 
the physician who was supervising the questionnaire 
completion. To encourage open communication about 
CAM use by patients, oncologists should be familiar 
with the most popular remedies and know where to fi nd 
reliable information for themselves and for their pa-
tients10. Th e cost could also be one of the reasons for 
deciding to use or not to use CAM, since almost half of 
the patients included in the study had low income (<400 
€), and average cost of monthly CAM therapy was 114 
€. Statistical analysis yielded correlation between higher 
income and higher CAM use.
It was found that 61 heterogeneous CAM thera-
pies were used and the most popular among the pa-
tients were naturopathy/folk medicine (reported by 
67.1% of CAM users), specifi c commercially available 
food supplements (33.5%), and medicinal herbs 
(32.9%), which is generally similar to the results of 
some previous studies11-13. It is interesting that none of 
the patients underwent acupuncture, according to sev-
eral reports the most commonly used CAM modality 
worldwide14. It was probably due to the specifi c cul-
tural way of life, which is also an important factor of 
the patient lifestyle15. Patients typically used more 
than one CAM therapy (on average 2.3 per patient), 
and two patients applied even 7 diff erent CAM ap-
proaches at the time, which in turn complicates under-
standing of the potential benefi ts of the therapies ad-
ministered. Although the patients using CAM may be 
at a risk of side eff ects and potential interactions with 
the main oncologic treatment, especially when several 
CAM therapies are used together, only 23% of the pa-
tients were aware of this fact. However, CAM therapy 
was generally well tolerated, and only several patients 
(8.7%) reported side eff ects, including vomiting and 
diarrhea, which are often also caused by standard treat-
ment, especially chemotherapy, concluding that even 
these small numbers may be exaggerated. On the other 
hand, several studies have reported the potential side 
eff ects of CAM, including allergic contact dermatitis 
and organ toxicity (including liver, kidneys and heart) 
associated with medicinal herbs, mechanical injuries 
and infections (including hepatitis and bacterial endo-
carditis) with acupuncture, as well as various nutrition-
al defi ciencies (especially in infants and small children 
given strict alternative diets). Th e authors suggest that 
some herbs may also have carcinogenic properties16.
Almost half of the patients had metastatic disease, 
characterized in most of the cases by poor prognosis. 
Although no relevant clinical data are available to date, 
CAM may have a role in increasing hope and opti-
mism, and subsequent improvement in physical and 
psychosocial wellbeing. Some patients also believed 
that CAM could cure their disease, but most of them 
were more rational, as confi rmed in some previous 
studies9. In this study, the majority of CAM users re-
ported boosting their immune system as the main rea-
son for CAM therapies, while only 18 patients thought 
it could actually kill cancer cells. Th is is consistent with 
data suggesting that patients mostly used CAM after 
more aggressive therapeutic approaches, such as che-
motherapy and surgery, while none of them started us-
ing CAM during endocrine therapy or immunothera-
py. Interestingly, although inadequate physician-pa-
tient communication and dissatisfaction with some 
aspects of conventional health care may be contribut-
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ing factors to desperation, only two patients admitted 
that desperation was the reason for CAM use. A study 
by Burstein et al. investigating breast cancer patients 
showed that those patients that were more depressed 
and had greater fear of recurrence were more prone to 
using CAM17. In our study, divorced patients used 
CAM signifi cantly more often than other groups of 
patients.
Even in the cases where there was no objective evi-
dence for eff ectiveness, patients were subjectively gen-
erally very satisfi ed with CAM therapies (Fig. 1). Th is 
may lead to the conclusion that, although there is no 
strong scientifi c evidence to recommend CAM, physi-
cians should not prohibit its use. Th is could be espe-
cially important in the palliative setting, when disease 
is incurable and maintaining the quality of life remains 
the main goal. Th us, health professionals should 
broaden their knowledge about CAM in order to pro-
vide complete and correct information to patients. In 
this study, the most common source of information 
about CAM was family and friends (41%), other pa-
tients (20.5%), and Internet (15.5%). Th ese sources are 
potentially very biased, not adjusted to the individual 
characteristics of the patient, and could even provide 
incorrect information18. Patients are obviously aware 
of this fact, and most of them could not decide wheth-
er to recommend CAM they used to other cancer pa-
tients. In contrast, only 12 of our patients got the in-
formation about CAM from their general practitioner, 
and 11 from their pharmacist.
In conclusion, considering the fact that a large pro-
portion of patients used at least one CAM approach, 
we need to continue our eff orts to improve patient-
oncologist communication and initiate research to de-
termine the possible standard of medicine-CAM in-
teractions, as well as the eff ectiveness of specifi c CAM 
approaches. Since it is estimated that cancer incidence 
will continue to rise, the uncertainties regarding CAM 
will become even more important and CAM users, if 
trends continue, even more numerous. Additionally, 
according to the available data, CAM therapies are 
used not only for malignant diseases, but for a vast 
number of diff erent medical conditions as well19. As 
patients become more knowledgeable of these ap-
proaches, working with the practitioners from various 
disciplines will become an integral part of cancer pa-
tient care. To date, although extensive CAM use 
among cancer patients has been recognized, the im-
pact of CAM on cancer patient survival and quality of 
life has been explored only sporadically. Th us, we need 
to broaden our understanding of the concepts of CAM 
by increased funding of CAM research. CAM thera-
pies that help manage pain, nausea, fatigue, anxiety, 
and other symptoms should be integrated in the pa-
tient overall care.
Learning points
• the prevalence of CAM use among cancer pa-
tients is high, 60.3% in this study;
• a large number of heterogeneous CAM thera-
pies are used by cancer patients, increasing the 
risk of the possible standard medicine-CAM 
interactions;
• considering the high prevalence of CAM use 
among cancer patients, we need to continue our 
eff orts to improve patient-oncologist communi-
cation;
• eff ectiveness of the specifi c CAM approaches 
are still not well known;
• understanding the concept of CAM should be 
broadened by increased funding of CAM re-
search; and
• CAM therapies that help manage pain, nausea, 
fatigue, anxiety, and other symptoms should be 
integrated in the patient overall care.
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Sažetak
UPOTREBA ALTERNATIVNE I KOMPLEMENTARNE MEDICINE 
U BOLESNIKA S MALIGNIM BOLESTIMA U VELIKOM ONKOLOŠKOM CENTRU 
I GLEDIŠTA NA BUDUĆNOST
D. Kust, I. Šamija, J. Marić-Brozić, B. Svetec, M. Miletić, G. Mamić, A. Bolanča, Z. Kusić i A. Fröbe
Proširenost upotrebe komplementarne i alternativne medicine (KAM) u posljednjih nekoliko desetljeća u stalnom je 
porastu, dobivajući sve veće medicinsko, ekonomsko i sociološko značenje. Cilj ovoga istraživanja bio je procijeniti prošire-
nost upotrebe KAM u onkoloških bolesnika u Hrvatskoj. Studija je dizajnirana kao presječno, deskriptivno, pregledno istra-
živanje te je provedena u obliku anonimnog upitnika. Istraživanje je provedeno na onkološkoj i hematološkoj klinici klinič-
kog bolničkog centra s velikim obrtajem onkoloških bolesnika. Ukupno 267 bolesnika koji su dali svoj informirani pristanak 
bilo je uključeno u studiju. Nakon statističke analize utvrđena je učestalost upotrebe KAM kod onkoloških bolesnika 60,3%. 
Pokazalo se da je korišten ukupno 61 različit oblik KAM, a najpopularnija alternativna terapija među bolesnicima bila je 
naturopatija/narodna medicina. U multivarijatnoj logističkoj regresijskoj analizi nezavisni prediktori povezani uz korištenje 
KAM bili su visoka primanja, razveden/a stanje, ženski spol i mlađa dob. S obzirom na činjenicu da značajan udio bolesnika 
koristi barem jedan oblik KAM nužno je nastaviti djelovanje u smjeru poboljšanja komunikacije između bolesnika i onkolo-
ga te razmisliti o integraciji onih KAM terapija koje imaju pozitivan učinak u uklanjanju boli, mučnine, umora, anksioznosti 
i drugih simptoma u cjelokupnu onkološku skrb.
Ključne riječi: Alternativna medicina; Rak; Komplementarna medicina; Onkologija; Hrvatska
